Epidural, Intrathecal Pharmacokinetics, and Intrathecal Bioavailability of Ropivacaine
Authors:
- Jean-Pierre EstebeJEJean-Pierre Estebe
- Maja RatajczakMRMaja Ratajczak
- Eric WodeyEWEric Wodey
- François ChevanneFCFrançois Chevanne
- Gilles DolloGDGilles Dollo
- David BecDBDavid Bec
- Jean-Marc MalinovskyJMJean-Marc Malinovsky
- Claude EcoffeyCEClaude Ecoffey
- Pascal Le CorrePCPascal Le Corre
- 1 September 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 105 (3) , 859-867
Abstract
Ropivacaine is used by the epidural route for postoperative pain management with various neuraxial techniques. Given the widespread use of these techniques and the relative paucity of data on spinal disposition of local anesthetics, we evaluated through an experimental animal model, the spinal disposition of ropivacaine, allowing further studies of factors influencing their intrathecal bioavailability. Sheep received an IV bolus dose of ropivacaine (50 mg), and 1 wk after, an intrathecal dose of ropivacaine (20 mg) followed 3 h later by epidural ropivacaine (100 mg). A simultaneous microdialysis technique was used to measure epidural and intrathecal drug concentrations after both epidural and intrathecal administrations. Absorption-time plots showed a large variability in the systemic absorption after both intrathecal and epidural administration, with an apparent faster systemic absorption after intrathecal administration. In the intrathecal space, the elimination clearance was around three-times higher than the distribution clearance. In the epidural space, the relative contribution of elimination and distribution to ropivacaine disposition was different, indicating a more pronounced influence of the distribution process. The intrathecal bioavailability after epidural administration was 11.1% +/- 7.6%. Using an animal model, we showed that drug dispositions in the intrathecal and epidural compartments are different, and that the intrathecal bioavailability of ropivacaine after epidural administration is low, and highly variable.Keywords
This publication has 27 references indexed in Scilit:
- Epidural, Cerebrospinal Fluid, and Plasma Pharmacokinetics of Epidural Opioids (Part 2)Anesthesiology, 2003
- Epidural, Cerebrospinal Fluid, and Plasma Pharmacokinetics of Epidural Opioids (Part 1)Anesthesiology, 2003
- The Effects of Bupivacaine, L-Nitro-L-Arginine-Methyl Ester, and Phenylephrine on Cardiovascular Adaptations to Asphyxia in the Preterm Fetal LambAnesthesia & Analgesia, 1997
- Pharmacokinetics of Alfentanil after Epidural AdministrationAnesthesiology, 1994
- The CSF and Plasma Pharmacokinetics of Sufentanil after Intrathecal AdministrationAnesthesiology, 1991
- The Effect of Age on Systemic Absorption and Systemic Disposition of Bupivacaine after Subarachnoid AdministrationAnesthesiology, 1991
- Cardiovascular Effects and Regional Clearances of Intravenous Ropivacaine in SheepAnesthesia & Analgesia, 1990
- Cerebral blood flow and oxygen consumption during isoflurane and halothane anesthesia in manActa Anaesthesiologica Scandinavica, 1988
- Pharmacokinetics of Epidural Morphine and Meperidine in HumansAnesthesiology, 1987
- Hepatic Clearance of Lidocaine During N2O Anesthesia in DogsAnesthesia & Analgesia, 1976